Peripheral nervous system (PNS): structure, function and clinical overview

Major subdivisions and organization

Anatomically and functionally the PNS is often divided into several branches. The somatic nervous system relays conscious sensations and controls voluntary skeletal muscle. The autonomic nervous system regulates involuntary activities such as heart rate, blood pressure, digestion and glandular secretion; it classically includes sympathetic and parasympathetic divisions. The enteric nervous system is a large intrinsic network within the gut wall that governs motility and secretion and can operate with considerable autonomy while still communicating with autonomic centers. Peripheral nerves include cranial nerves (emerging from the brainstem) and spinal nerves (emerging from the spinal cord) that carry mixed sensory and motor fibers to defined body regions.

Microscopic structure and conduction

Nerves are bundles of axons (nerve fibers) sheathed by connective tissue. Many axons are wrapped in myelin, a lipid-rich insulation produced in the PNS by Schwann cells; myelin increases conduction speed. Unmyelinated fibers and small-diameter fibers conduct more slowly and often carry pain and autonomic signals. Signal transmission depends on ion channels and the membrane properties of axons; injury or metabolic disturbance can impair conduction and produce sensory loss or weakness.

Vulnerability and protection

Unlike the CNS, the PNS lacks the rigid bone protection of the skull and vertebral column and is exposed to compression, traction and external toxins (bone). Although peripheral nerves are supported by connective tissue and vascular supply, they are susceptible to trauma, entrapment (for example, carpal tunnel), ischemia and metabolic injury such as diabetic neuropathy affecting the limbs and sensory function. Autonomic neuropathies may impair control of organs including the heart and digestive tract.

Repair and clinical considerations

The PNS has greater regenerative capacity than the CNS when neuronal cell bodies survive. After axonal injury, a process of Wallerian degeneration clears distal axon segments and Schwann cells provide guidance for regrowing axons; clinical recovery depends on injury severity, distance to target and timely management. Common clinical conditions include traumatic nerve injury, compressive neuropathies, metabolic neuropathies (for example related to diabetes), inflammatory disorders (such as Guillain–Barré syndrome) and toxic neuropathies.

Diagnosis and management

• Diagnosis: clinical examination and history, supplemented by tests such as nerve conduction studies and electromyography, which assess conduction and muscle response.
• Imaging and laboratory tests help identify metabolic, immune or structural causes.
• Treatment: ranges from conservative measures (rest, splints, physical therapy, metabolic control) to pharmacologic symptom management (analgesics, neuropathic pain agents) and surgical repair or decompression when indicated. Rehabilitation aims to restore function and prevent secondary complications.

Research and practical outlook

Ongoing research seeks to improve outcomes after peripheral nerve injury, refine microsurgical techniques, enhance nerve regeneration and prevent neuropathy through better metabolic and toxic exposure control. Understanding the distinctions between the PNS and the CNS is essential for diagnosis, treatment planning and patient prognosis because their anatomy, regenerative potential and protective environments differ substantially.

For authoritative summaries and diagrams, consult standard physiology and clinical neurology resources that cover peripheral nerve anatomy, sensory systems and autonomic regulation; professional clinical guidelines address evaluation and management of common PNS disorders.